Vaccine development research is necessary for controlling transmission, improving community immunity, and preventing further SARS-CoV-2 resurgence. Vaccine-originated immunity is one of the most effective ways to protect human life, yet viruses are always evolving. Therefore, it is critical to select a vaccine approach and begin with basic lab research to identify the pathogen and antigen candidates that could cause an immune response, as well as study and understand host immune response to improve vaccine development. The various approaches to future vaccine development can be broadly classified into either protein subunit, plasmid DNA, mRNA, or viral vaccines.
Vaccine development research is necessary for controlling transmission, improving community immunity, and preventing further SARS-CoV-2 resurgence. Vaccine-originated immunity is one of the most effective ways to protect human life, yet viruses are always evolving. Therefore, it is critical to select a vaccine approach and begin with basic lab research to identify the pathogen and antigen candidates that could cause an immune response, as well as study and understand host immune response to improve vaccine development. The various approaches to future vaccine development can be broadly classified into either protein subunit, plasmid DNA, mRNA, or viral vaccines.
At Fisher Scientific (part of Thermo Fisher Scientific), we are proud to be a part of COVID-19 vaccine development and production locally and worldwide. We offer a broad range of products that support vaccine research, regardless of approach, enabling the speed and accuracy needed to shorten your development timeline, and eventually enabling large-scale cGMP production.
As vaccination drive reaching its peak in our region, we would like to pay tribute to all vaccine researchers worldwide by showcasing the original publication in Nature that details the development of BioNtech/Pfizer BNT162b mRNA vaccine
Extracted from Extended Data Fig. 1c, Western blot of denatured and non-denatured samples of size-exclusion chromatography fractions of concentrated medium from HEK293T cells transfected with BNT162b1 RNA. Image captured with Vilber Fusion FX Imager.
The information below is required for social login
Sign In
Create New Account
Vaccine development research is necessary for controlling transmission, improving community immunity, and preventing further SARS-CoV-2 resurgence. Vaccine-originated immunity is one of the most effective ways to protect human life, yet viruses are always evolving. Therefore, it is critical to select a vaccine approach and begin with basic lab research to identify the pathogen and antigen candidates that could cause an immune response, as well as study and understand host immune response to improve vaccine development. The various approaches to future vaccine development can be broadly classified into either protein subunit, plasmid DNA, mRNA, or viral vaccines.
Vaccine development research is necessary for controlling transmission, improving community immunity, and preventing further SARS-CoV-2 resurgence. Vaccine-originated immunity is one of the most effective ways to protect human life, yet viruses are always evolving. Therefore, it is critical to select a vaccine approach and begin with basic lab research to identify the pathogen and antigen candidates that could cause an immune response, as well as study and understand host immune response to improve vaccine development. The various approaches to future vaccine development can be broadly classified into either protein subunit, plasmid DNA, mRNA, or viral vaccines.
At Fisher Scientific (part of Thermo Fisher Scientific), we are proud to be a part of COVID-19 vaccine development and production locally and worldwide. We offer a broad range of products that support vaccine research, regardless of approach, enabling the speed and accuracy needed to shorten your development timeline, and eventually enabling large-scale cGMP production.
As vaccination drive reaching its peak in our region, we would like to pay tribute to all vaccine researchers worldwide by showcasing the original publication in Nature that details the development of BioNtech/Pfizer BNT162b mRNA vaccine
Extracted from Extended Data Fig. 1c, Western blot of denatured and non-denatured samples of size-exclusion chromatography fractions of concentrated medium from HEK293T cells transfected with BNT162b1 RNA. Image captured with Vilber Fusion FX Imager.
Additional Resources:
Contact Us